"Hypotyrosinemia" in phenylketonuria.
It has been postulated that the significant incidence of learning disabilities in well-treated patients with phenylketonuria (PKU) may be due, in part, to reduced production of neurotransmitters as a result of deficient tyrosine transport across the neuronal cell membrane. Hypotyrosinemia has been reported in treated and untreated PKU but virtually no data are available. We decided to examine this in our patient population and to compare it with the published norms, patient data from our hospital clinical biochemical laboratory database, and a group of normal children and adolescents in a private pediatric practice. We found that the mean nonfasting plasma tyrosine in 99 classical PKU patients was 41.1 micromol/L, in 26 mild (atypical) PKU patients 53.3 micromol/L, and in 35 non-PKU mild hyperphenylalaninemia patients 66.6 micromol/L. This compared to nonfasting plasma tyrosine levels in 102 non-PKU subjects of 64.0 micromol/L in our hospital biochemistry database, 69.1 micromol/L in 58 volunteers in the private office practice, and 64-78.8 micromol/L in infants, children, and adolescents in the literature review. Our data support the previously undocumented statements in the literature that plasma tyrosine levels are low in PKU.
Hanley
W B
WB
Division of Clinical & Biochemical Genetics, The Hospital for Sick Children, Toronto, Ontario, Canada. whanley@sickkids.on.ca
Lee
A W
AW
Hanley
A J
AJ
Lehotay
D C
DC
Austin
V J
VJ
Schoonheyt
W E
WE
Platt
B A
BA
Clarke
J T
JT
D000293:Adolescent; D000328:Adult; D000704:Analysis of Variance; D002648:Child; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D010649:Phenylalanine / Q000097:blood; D010661:Phenylketonurias / Q000097:blood* / Q000473:pathology; D012196:Review Literature as Topic; D012720:Severity of Illness Index; D014443:Tyrosine / Q000097:blood*
D014443:Tyrosine; D010649:Phenylalanine